Therapeutic targeting of the insulin-like growth factor-I receptor (IGF-IR) plus oxaliplatin decreases hepatic growth of human colon cancer
T. W. Bauer, M. F. McCarty, J. Wey, A. Belcheva, R. J. Somcio, F. Fan, W. Liu, R. Singh, L. M. EllisVolume:
11
Language:
english
Pages:
1
DOI:
10.1007/bf02524016
Date:
February, 2004
File:
PDF, 160 KB
english, 2004